Header Logo

Connection

ELIAS JOSEPH JABBOUR to Immunotoxins

Back to Details
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Immunotoxins.
ELIAS JOSEPH JABBOUR
Connection Strength
0.132
Immunotoxins
  1. A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2016 Mar; 16(3):139-45.
    View in: PubMed
    Score: 0.132
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.